Lipitor, which was brought to market in 1996, is a statin drug used to treat high cholesterol. Lipitor works by reducing levels of “bad” cholesterol (low-density lipoprotein, or LDL) and triglycerides in the blood, while increasing levels of “good” cholesterol. Prior to its loss of patent protection in 2011, Lipitor generated peak sales of $13 billion a year for Pfizer, Inc.
Lipitor lawsuit claims have been filed on behalf of individuals who developed type 2 diabetes, allegedly due to their use of Lipitor. Lipitor diabetes lawsuits allege that Pfizer failed to provide adequate warnings regarding the drug’s association with the disease. They also allege that warnings Pfizer added to the Lipitor label in 2012 remain inadequate.
Lipitor and similar drugs have been linked to a number of serious side effects, including:
Yes. In 2012, the FDA ordered Pfizer, Inc. to add new warnings to the Lipitor label regarding an increased risk of new-onset diabetes in patients who took Lipitor. The FDA took action after a study published in JAMA: Internal Medicine reported that post-menopausal women treated with the statin may be at an increased risk for developing the disease.
Patients who take this statin should notify their doctor if they experience any symptoms of Lipitor diabetes, including:
There has not been a Lipitor recall due to the medication’s association with Type 2 diabetes or any other side effects. However, Ranbaxy Pharmaceuticals, Inc. announced a recall for generic Lipitor in November 2012, after it was discovered that some lots of the medication had been contaminated with tiny glass particles.
As of October 2013, Lipitor side effect lawsuits filed in Illinois federal court had been consolidated before a single judge in U.S. District Court, Southern District of Illinois, for the purposes of discovery and other pretrial proceedings. At the same time, a number of Lipitor diabetes claims were also being informally handled in a consolidated manner in U.S. District Court, District of South Carolina. In April 2013, plaintiffs in Lipitor lawsuits filed a petition with the U.S. Judicial Panel on Multidistrict Litigation (JPML) seeking the creation of a single multidistrict litigation for all federally-filed Lipitor type 2 diabetes claims, but the request was denied. However, plaintiffs renewed their petition in October 2013, as the litigation surrounding Lipitor continued to grow.
Unless we obtain a recovery on your behalf, it will cost you nothing to retain a Lipitor attorney through Bernstein Liebhard LLP. Our Firm is accepting these cases on a contingency basis, which means our clients only pay attorney’s fees if we are able to secure a judgment or settlement in their case. If your Lipitor lawsuit is not resolved in your favor, you will owe our Firm nothing. The details of this arrangement will be fully spelled out in the retainer agreement you sign with Bernstein Liebhard LLP.
Product liability lawsuits, including those involving allegations of Lipitor diabetes, are subject to a statute of limitations that sets very strict deadlines for when a claim must be filed. This deadline varies from state to state. To ensure your lawsuit is not time-barred, it is vital that you contact Bernstein Liebhard LLP as soon as possible, so that our attorneys can see to it that your case is filed in a timely manner.
No. The Lipitor lawsuits being pursued by Bernstein Liebhard LLP claim, among other things, that Pfizer, Inc. failed to provide adequate warnings to patients and doctors regarding the association between Lipitor and diabetes. Pfizer, Inc. is the primary defendant, and doctors are not named in the lawsuits.
Yes, while our Firm is based in New York City, we represent clients from all over the U.S. Our Lipitor lawyers are offering free legal evaluations to people in all 50 states.
If you choose to move forward with a Lipitor lawsuit, you will need to keep track of your medical expenses and time missed work due to your injury, so that your attorney can calculate a fair level of compensation. You will also need to sign a medical release giving Bernstein Liebhard LLP access to your medical records, and you may need to be available to testify at a deposition or during a trial.
While this can vary greatly depending on the extent of your injury and the complexity of the case, most product liability lawsuits take at least two years to come to trial. While many cases do settle before trial, this is unlikely to happen before your Lipitor lawsuit has been fully prepped for trial.
Since 1993, Bernstein Liebhard LLP has successfully represented hundreds of people injured by harmful consumer products, including defective drugs. To date, we have recovered more than $3 billion for our clients. You can expect the same high level of service we provide to all of our clients if you choose our Firm for your Lipitor diabetes lawsuit.
Please contact the Lipitor lawyers at Bernstein Liebhard LLP for your free case review. Our legal staff will fully explain all of the options available to you, and you’ll be under no obligation whatsoever. For more information, call our office today at .